Cookie policy notice

By continuing to use this site you agree to our cookies policy below:
Since 26 May 2011, the law now states that cookies on websites can ony be used with your specific consent. Cookies allow us to ensure that you enjoy the best browsing experience.

This site is intended for health professionals only

At the heart of general practice since 1960

Study shows clopidogrel rebound risk

By Nigel Praities

US researchers have shown for the first time a rebound in death or myocardial infarction after high-risk patients stop taking clopidogrel.

The study followed patients discharged from hospital for acute coronary syndrome and found they had almost double the risk of dying or having an acute myocardial infarction within the first 90 days of ceasing clopidogrel treatment.

Dr Kathryn Griffith, a GP in York and a board member of the Primary Care Cardiovascular Society, said this evidence supported monitoring high-risk patients closely before taking them off clopidogrel.

‘If a patient has not been genuinely stable while they have been on clopidogrel, then it is difficult to justify stopping it,' she said.

The research appears in the latest edition of the Journal of the American Medical Association.

Rate this article 

Click to rate

  • 1 star out of 5
  • 2 stars out of 5
  • 3 stars out of 5
  • 4 stars out of 5
  • 5 stars out of 5

0 out of 5 stars

Have your say